194 related articles for article (PubMed ID: 33742285)
1. Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients.
Grillo PK; Győrffy B; Götte M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1937-1955. PubMed ID: 33742285
[TBL] [Abstract][Full Text] [Related]
2. Glypican-3 Differentiates Intraductal Carcinoma and Paget's Disease from Other Types of Breast Cancer.
Alshammari FO; Satari AO; Aljabali AS; Al-Mahdy YS; Alabdallat YJ; Al-Sarayra YM; Alkhojah MA; Alwardat ARM; Haddad M; Al-Sarayreh SA; Al-Saraireh YM
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676710
[No Abstract] [Full Text] [Related]
3. Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients.
Jeon Y; Kim H; Jang ES; Hong S; Kim JW; Yoon YS; Cho JY; Han HS; Jeong SH
APMIS; 2016 Mar; 124(3):208-15. PubMed ID: 26764243
[TBL] [Abstract][Full Text] [Related]
4. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
Matsuda K; Maruyama H; Guo F; Kleeff J; Itakura J; Matsumoto Y; Lander AD; Korc M
Cancer Res; 2001 Jul; 61(14):5562-9. PubMed ID: 11454708
[TBL] [Abstract][Full Text] [Related]
5. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
[TBL] [Abstract][Full Text] [Related]
6. Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans.
Yoneda A; Lendorf ME; Couchman JR; Multhaupt HA
J Histochem Cytochem; 2012 Jan; 60(1):9-21. PubMed ID: 22205677
[TBL] [Abstract][Full Text] [Related]
7. Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans.
Veugelers M; De Cat B; Ceulemans H; Bruystens AM; Coomans C; Dürr J; Vermeesch J; Marynen P; David G
J Biol Chem; 1999 Sep; 274(38):26968-77. PubMed ID: 10480909
[TBL] [Abstract][Full Text] [Related]
8. The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation.
de Moraes GFA; Listik E; Justo GZ; Vicente CM; Toma L
BMC Mol Cell Biol; 2021 May; 22(1):26. PubMed ID: 33947326
[TBL] [Abstract][Full Text] [Related]
9. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
10. Glypican-3 expression is silenced in human breast cancer.
Xiang YY; Ladeda V; Filmus J
Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
[TBL] [Abstract][Full Text] [Related]
11. The Role of Glypicans in Cancer Progression and Therapy.
Li N; Spetz MR; Ho M
J Histochem Cytochem; 2020 Dec; 68(12):841-862. PubMed ID: 32623934
[TBL] [Abstract][Full Text] [Related]
12. Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer.
Han S; Ma X; Zhao Y; Zhao H; Batista A; Zhou S; Zhou X; Yang Y; Wang T; Bi J; Xia Z; Bai Z; Garkavtsev I; Zhang Z
Oncotarget; 2016 Jul; 7(28):44406-44416. PubMed ID: 27259271
[TBL] [Abstract][Full Text] [Related]
13. Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database.
Moek KL; Fehrmann RSN; van der Vegt B; de Vries EGE; de Groot DJA
Am J Pathol; 2018 Sep; 188(9):1973-1981. PubMed ID: 29935166
[TBL] [Abstract][Full Text] [Related]
14. Glypicans as Cancer Therapeutic Targets.
Li N; Gao W; Zhang YF; Ho M
Trends Cancer; 2018 Nov; 4(11):741-754. PubMed ID: 30352677
[TBL] [Abstract][Full Text] [Related]
15. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.
Malavaki CJ; Roussidis AE; Gialeli C; Kletsas D; Tsegenidis T; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2477-89. PubMed ID: 23374223
[TBL] [Abstract][Full Text] [Related]
16. Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells.
Kwack MH; Choi BY; Sung YK
Mol Cells; 2006 Apr; 21(2):224-8. PubMed ID: 16682817
[TBL] [Abstract][Full Text] [Related]
17. Glypicans in growth control and cancer.
Filmus J
Glycobiology; 2001 Mar; 11(3):19R-23R. PubMed ID: 11320054
[TBL] [Abstract][Full Text] [Related]
18. Glypican-6 and Glypican-4 stimulate embryonic stomach growth by regulating Hedgehog and noncanonical Wnt signaling.
Shi W; Filmus J
Dev Dyn; 2022 Dec; 251(12):2015-2028. PubMed ID: 36057966
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
20. The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling.
Melleby AO; Strand ME; Romaine A; Herum KM; Skrbic B; Dahl CP; Sjaastad I; Fiane AE; Filmus J; Christensen G; Lunde IG
PLoS One; 2016; 11(10):e0165079. PubMed ID: 27768722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
